ID   CUTO-3.29
AC   CVCL_UJ35
SY   CUTO3.29; Colorado University Thoracic Oncology-3.29
DR   Wikidata; Q93460571
RX   PubMed=26216294;
CC   Sequence variation: Gene fusion; HGNC; HGNC:30321; MPRIP + HGNC; HGNC:8031; NTRK1; Name(s)=MPRIP-NTRK1; Note=MPRIP exon 21 fused to NTRK1 exon 14 (PubMed=26216294).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8TE ! CUTO-3
SX   Female
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
RX   PubMed=26216294; DOI=10.1158/2159-8290.CD-15-0443; PMCID=PMC4635026;
RA   Doebele R.C., Davis L.E., Vaishnavi A., Le A.T., Estrada-Bernal A.,
RA   Keysar S., Jimeno A., Varella-Garcia M., Aisner D.L., Li Y.-L.,
RA   Stephens P.J., Morosini D., Tuch B.B., Fernandes M., Nanda N.,
RA   Low J.A.;
RT   "An oncogenic NTRK fusion in a patient with soft-tissue sarcoma with
RT   response to the tropomyosin-related kinase inhibitor LOXO-101.";
RL   Cancer Discov. 5:1049-1057(2015).
//